148 related articles for article (PubMed ID: 37965255)
41. Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2.
Li J; Gao Z; Chen J; Cheng R; Niu J; Zhang J; Yang Y; Yuan X; Xia J; Mao G; Liu H; Dong Y; Wu C
Front Cell Infect Microbiol; 2022; 12():953027. PubMed ID: 36061868
[TBL] [Abstract][Full Text] [Related]
42. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites.
Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850
[TBL] [Abstract][Full Text] [Related]
43. SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
Seidel A; Hoffmann S; Jahrsdörfer B; Körper S; Ludwig C; Vieweg C; Albers D; von Maltitz P; Müller R; Lotfi R; Wuchter P; Klüter H; Kirchhoff F; Schmidt M; Münch J; Schrezenmeier H
Front Immunol; 2023; 14():1170759. PubMed ID: 37180152
[TBL] [Abstract][Full Text] [Related]
44. Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection.
Yang J; Hong W; Lei H; He C; Lei W; Zhou Y; Zhao T; Alu A; Ma X; Li J; Yang L; Wang Z; Wang W; Lu G; Shen G; Lu S; Wu G; Shi H; Wei X
Signal Transduct Target Ther; 2023 Jun; 8(1):252. PubMed ID: 37336889
[TBL] [Abstract][Full Text] [Related]
45. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
[TBL] [Abstract][Full Text] [Related]
46. Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants.
Nagasawa N; Kimura R; Akagawa M; Shirai T; Sada M; Okayama K; Sato-Fujimoto Y; Saito M; Kondo M; Katayama K; Ryo A; Kuroda M; Kimura H
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764181
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
[TBL] [Abstract][Full Text] [Related]
48. A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2.
Groza C; Totschnig D; Wenisch C; Atamaniuk J; Zoufaly A
Sci Rep; 2023 May; 13(1):7896. PubMed ID: 37193727
[TBL] [Abstract][Full Text] [Related]
49. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia.
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
Respir Investig; 2024 May; 62(3):384-387. PubMed ID: 38452443
[TBL] [Abstract][Full Text] [Related]
50. Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants.
Bhattacharya M; Chatterjee S; Lee SS; Dhama K; Chakraborty C
Drug Resist Updat; 2023 Nov; 71():101008. PubMed ID: 37757651
[TBL] [Abstract][Full Text] [Related]
51. As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
Xu R; Wang W; Zhang W
Front Public Health; 2022; 10():1039123. PubMed ID: 36504951
[TBL] [Abstract][Full Text] [Related]
52. Phylogenetic, Sequencing, and Mutation Analysis of SARS-CoV-2 Omicron (BA.1) and Its Subvariants (BA.1.1, BA.2) During the Fifth Wave of the COVID-19 Pandemic in the Iraqi Kurdistan Region.
Taher SM; Abdo JM; Merza MA
Cureus; 2023 Nov; 15(11):e48637. PubMed ID: 38090439
[TBL] [Abstract][Full Text] [Related]
53. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
[TBL] [Abstract][Full Text] [Related]
54. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.
Gong SY; Ding S; Benlarbi M; Chen Y; Vézina D; Marchitto L; Beaudoin-Bussières G; Goyette G; Bourassa C; Bo Y; Medjahed H; Levade I; Pazgier M; Côté M; Richard J; Prévost J; Finzi A
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298733
[TBL] [Abstract][Full Text] [Related]
55. Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants.
Pokorska-Śpiewak M; Pawłowska M; Ciechanowski P; Peregrym M; Dobrzeniecka A; Sobolewska-Pilarczyk M; Franczak J; Majda-Stanisławska E; Szczepańska B; Zaleska I; Flisiak R
Pediatr Infect Dis J; 2024 Feb; 43(2):149-154. PubMed ID: 37922516
[TBL] [Abstract][Full Text] [Related]
56. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
[TBL] [Abstract][Full Text] [Related]
57. Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
Chenchula S; Amerneni KC; Ghanta MK; Padmavathi R; Chandra MB; Adusumilli MB; Chavan M; Mudda S; Gupta R; Lakhawat B
Virology; 2023 Jul; 584():38-43. PubMed ID: 37229914
[TBL] [Abstract][Full Text] [Related]
58. Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.
Wilhelm A; Widera M; Grikscheit K; Toptan T; Schenk B; Pallas C; Metzler M; Kohmer N; Hoehl S; Marschalek R; Herrmann E; Helfritz FA; Wolf T; Goetsch U; Ciesek S
EBioMedicine; 2022 Aug; 82():104158. PubMed ID: 35834885
[TBL] [Abstract][Full Text] [Related]
59. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
60. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.
Tauzin A; Nicolas A; Ding S; Benlarbi M; Medjahed H; Chatterjee D; Dionne K; Gong SY; Gendron-Lepage G; Bo Y; Perreault J; Goyette G; Gokool L; Arlotto P; Morrisseau C; Tremblay C; Martel-Laferrière V; De Serres G; Levade I; Kaufmann DE; Côté M; Bazin R; Finzi A
Cell Rep; 2023 Jan; 42(1):111998. PubMed ID: 36656710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
